CS Paper Radar

scHFBiMamba: a bidirectional Mamba autoencoder for cardiac disease-state classification from single-nucleus RNA-seq data

Ugo Lomoio, Pietro Hiram Guzzi, Pierangelo Veltri

cs.LG cs.AI ·submitted 2026-10-10 18:47 UTC · v1
benchmarkcode/data

Abstract

To evaluate whether a compact bidirectional state-space autoencoder improves joint classification of species, cell type, and disease state from single-nucleus RNA-sequencing profiles in heart failure (HF), while yielding interpretable gene attributions. Building on the dense denoising autoencoder (DAE) and MLP framework of Ruz Jurado et al., we developed scHFBiMamba, combining a bidirectional Mamba autoencoder (BiMambaAE) with an MLP head. BiMambaAE maps 16,545-gene profiles to 350-dimensional latent representations using 13.2M parameters, about 14.6-fold fewer than the dense DAE (192.9M). We compared six encoder-classifier configurations on 38,275 held-out cardiac nuclei using McNemar tests with Benjamini-Hochberg correction, and assessed nine classifiers on frozen representations. Biological relevance was evaluated by comparing SHAP-derived differentially explained genes with differentially expressed genes against curated HF-related Gene Ontology keywords. BiMambaAE+MLP achieved the highest aggregate F1: pooled macro-F1 across 13 outputs was 0.966 versus 0.957 for DAE+MLP, and the mean category macro-F1 was 0.977 versus 0.970. It significantly improved cell-type and disease-state accuracy (adjusted p=7.1e-3 and p=4.8e-6, respectively), with species F1 of 1.000. SHAP-derived differentially explained genes achieved a pathway-enrichment benchmark F1 of 0.105 versus 0.053 for differentially expressed genes. Compact bidirectional state-space autoencoders can outperform substantially larger dense autoencoders for joint cardiac transcriptomic classification while reducing parameters. scHFBiMamba enables accurate multi-task prediction and hypothesis-generating gene-level interpretation. Code: https://github.com/UgoLomoio/scHFBiMamba.

Closest papers

Nearest neighbours by meaning across the whole index.

BarcodeMAE+: Rethinking Masked Pretraining and Global Representations for DNA Barcode Foundation Models

cs.LG q-bio.GN ·2026-09-26 ·Monireh Safari, Pablo Millan Arias, Scott C. Lowe, Lila Kari, Angel X. Chang +1 more
similarity 0.59
Abstract

Many DNA foundation models are pretrained by masking parts of a sequence and asking the model to reconstruct them. Standard masked pretraining exposes the encoder to special [MASK] tokens that are absent at inference, creating a mismatch between training and downstream use. The role of an explicit global sequence representation such as a [CLS] token and how it should be trained also remain poorly understood for DNA barcodes. We introduce BarcodeMAE+ and study model architecture, global [CLS] representation, and auxiliary pretraining objectives across arthropod COI (BIOSCAN-5M) and fungal ITS (UNITE+INSD) barcodes. Across both barcode regions, the encoder-decoder MAE-LM architecture outperforms its matched encoder-only counterpart in nearly all evaluated configurations, supporting MAE-LM as an effective architectural design for DNA barcode foundation models. A trained global [CLS] representation provides substantial additional gains: on BIOSCAN-5M, [CLS] accuracy increases from 47.53% without an auxiliary objective to 80.65% with cross-entropy genus classification. The best auxiliary objective is region-dependent: cross-entropy performs best on BIOSCAN-5M, whereas pairwise same-genus classification performs best on UNITE+INSD, reaching 73.19% on Yeast and 63.07% on Filamentous Fungi. BarcodeMAE+ outperforms published DNA foundation model baselines on BIOSCAN-5M and achieves the highest Yeast accuracy among the evaluated UNITE+INSD baselines using frozen encoder representations. Similarity-weighted softmax KNN voting further stabilizes accuracy as neighbourhood size increases. Overall, encoder-decoder masked pretraining and an explicitly trained global representation are strong design choices for DNA barcode foundation models, while the optimal objective for learning that representation depends on the biological domain.

0.25

ORION-CMR: On-scanner Reporting with Integrated Foundation Model for End-to-End Cardiac MRI Analysis and Interpretation

eess.IV cs.CVcs.LGphysics.med-ph ·2026-09-20 ·Omer Burak Demirel, Kelly K. Horst, Alessio Perazzolo, Elisa Bruno, Kenan Kaya +13 more
similarity 0.54
Abstract

Cardiovascular magnetic resonance (CMR) provides comprehensive cardiac assessment but remains underutilized because of the complexity of acquisition, post-processing, and interpretation. Existing artificial intelligence (AI) methods address isolated tasks, limiting clinical integration. We present ORION-CMR (On-scanner Reporting with Integrated fOunda-tioN Model), the first clinically evaluated scanner-native end-to-end CMR foundation model. Pretrained on 12,896,733 CMR images from 9,258 studies, ORION-CMR performs sequence classification, ventricular function assessment, late gadolinium enhancement (LGE) detection, binary and multiclass disease classification, and local large language model-based report generation in approximately 90 seconds. The framework. was evaluated on public benchmarks and clinically validated in a multi-vendor cohort of 68 subjects with normal examinations, congenital heart disease, dilated cardiomyopathy, and myocardial infarction. ORION-CMR outperformed supervised baselines and the previously published CMR foundation model (CMR-FM), achieving state-of-the-art performance for LGE classification and scar segmentation. Clinical evaluation achieved an AUC of 0.96 for normal-versus abnormal classification and 0.88 for multiclass disease classification, while generated reports demonstrated 81.4% agreement with expert interpretation. These results demonstrate the feasibility of real-time scanner-native AI-assisted CMR analysis and automated report generation.

0.15

IsoAlign: Isoform-Aware DNA-Protein Alignment via Joint-Embedding Predictive Architectures

cs.LG ·2026-10-30 ·Niousha Sadjadi, Arman Seyed-Ahmadi, Tony Tu, Micaela Elisa Consens, Kerr Ding +6 more
similarity 0.54
Abstract

Genomic foundation models (GFMs) have emerged as a powerful paradigm for learning DNA sequence representations, yet existing self-supervised pretraining strategies overlook alternative splicing and underperform compared to specialized models. To address this gap, we introduce IsoAlign, a multimodal framework that grounds genomic pretraining in isoform-aware DNA-protein alignment to learn biologically meaningful representations. IsoAlign aligns transcripts to their corresponding protein isoforms, capturing both coding sequences and broader regulatory contexts, using two Joint-Embedding Predictive Architectures (JEPA): DNA-Protein JEPA (DP-JEPA), which predicts protein representations from DNA using contrastive alignment, and Isoform-Masked JEPA (IM-JEPA), which models relationships among alternative isoforms of the same gene through masked protein prediction. We evaluate the learned DNA representations of these architectures across a multi-metric evaluation suite spanning tasks, including the prediction of pathogenicity, fitness, gene expression, and TF binding. Our results demonstrate that isoform-aware cross-modal alignment using JEPA significantly improves functional representations and downstream performance, establishing a promising direction for GFM pretraining.

0.15

A Transformer-Based Delta Expression Encoder for Psilocybin Transcriptional Response: Architecture, Representations, and Biological Validation

cs.LG q-bio.GN ·2026-09-08 ·Sai Jayakumar
code/dataunusual similarity 0.54
Abstract · 23 pages, 8 figures. Code: https://github.com/saijaya/delta-expression-encoder. Checkpoints: https://doi.org/10.5281/zenodo.21095034

Understanding why individuals respond differently to psilocybin requires modeling the drug's transcriptional perturbation signature at the cell-type level. I present a Transformer-based delta expression encoder that learns to classify differential gene expression status - upregulated, downregulated, or neutral - from single-nucleus RNA-sequencing data, without supervision from pathway annotations or prior biological knowledge. The model is trained on pseudobulk profiles from 623 examples spanning 18 cell types, 2 drug conditions, and 6 timepoints derived from the Liao et al. 2025 dataset, and achieves 69.4% weighted classification accuracy. Three principal findings are reported, alongside one direct test of a published hypothesis that returned a result inconsistent with that hypothesis. First, per-cell-type classification accuracy ranges from 28.3% (L2/3 IT, a primary HTR2A-expressing psilocybin target) to 99.6% (endothelial cells), consistent with known psilocybin response biology. Second, psilocybin-induced transcriptional downregulation is significantly more stereotyped across individuals than upregulation (Mann-Whitney U=18615.0, p<0.0001), a novel finding with a cortical depth gradient across excitatory subtypes. Third, attention-guided gene co-regulation analysis recovers drug-specific modules without pathway supervision. Separately, a direct test of whether baseline HTR2A expression predicts drug-response separability across cell types found a significant negative correlation (Spearman r = -0.7088, p = 0.0021), the opposite of what a simple HTR2A-gating account would predict.

0.52

CARDINAL Predicts Cardiovascular Risk From Non-contrast Cardiac CT

eess.IV cs.AIcs.CVcs.LG+1 ·2026-08-27 ·Roy Gabriel, Nattakorn Kittisut, Jamshid Hassanpour, Michael Galarnyk, Abanoub Abdelmalak +4 more
similarity 0.54
Abstract

Cardiovascular risk prediction remains limited by incomplete clinical data and imaging biomarkers that reduce computed tomography (CT) to a small number of handcrafted features. We developed CARDINAL (Cardiovascular Assessment via Representation learning from Deep Imaging with Nested Anatomical Latent embeddings), a clinically grounded framework that learns compact representations from routine non-contrast cardiac CT for major adverse cardiovascular event (MACE) prediction. In 17,659 patients, CARDINAL was evaluated for 1-, 3-, 5-, and 10-year MACE prediction against American Heart Association (AHA) pooled cohort equations (PCE), AHA predicting risk of cardiovascular disease events (PREVENT), coronary artery calcium (CAC), segmentation-derived CT biomarkers, and 70-feature structural radiomics. Gains were largest at longer horizons. At 10 years, CARDINAL (joint) achieved an area under the receiver operating characteristic curve (AUROC) of 0.866 $\pm$ 0.020 and an area under the precision-recall curve (AUPRC) of 0.890 $\pm$ 0.015, compared with an AUROC of 0.826 $\pm$ 0.023 and an AUPRC of 0.826 $\pm$ 0.022 for structural radiomics, the strongest baseline. CARDINAL also achieved the highest survival concordance index (C-index), 0.753 $\pm$ 0.015, and high-versus-low risk-tertile hazard ratio, 10.78 $\pm$ 3.16, with favorable reclassification and exploratory calibration. These findings suggest that non-contrast cardiac CT contains prognostic information beyond conventional risk equations, CAC scoring, and engineered imaging biomarkers.

0.46

A Unified DINOv2-Based Framework for LVEF Estimation, GLS Dysfunction Classification, and Early Cardiotoxicity Prediction

eess.IV cs.CV ·2026-08-14 ·Xiaotong Zhang, Mingyue Cui, Qing Cao, Jingming Xia
published similarity 0.53
Abstract · Accepted as an oral at the EchoRisk Challenge Workshop, MICCAI 2026

Left ventricular ejection fraction (LVEF) estimation (Task 1), global longitu-dinal strain (GLS)-based dysfunction classification (Task 2), and early cardi-otoxicity prediction (Task 3) provide complementary information for cardio-oncology assessment. LVEF reflects macroscopic ventricular volume chang-es as the clinical standard, whereas GLS captures subtle myocardial defor-mation, indicating subclinical cardiotoxicity before overt LVEF decline. Fur-thermore, predicting cardiotoxicity from baseline echocardiography prior to treatment enables preventive interventions at an early stage. To address these three tasks, we employ a DINOv2-based framework with task-specific adap-tation and prediction heads. Built upon a frozen foundation encoder, the framework incorporates parameter-efficient Low-Rank Adaptation (LoRA) and temporal aggregation to learn task-specialized representations, ensuring robust generalization. Crucially, during inference, it operates in a fully cycle-detection-free and phase-free manner, requiring neither cardiac cycle seg-mentation nor explicit End-Diastolic/End-Systolic (ED/ES) annotations. Ad-ditionally, we introduce an ED/ES-guided 2D/3D hybrid multi-view regres-sion model specifically to optimize Task 1. On a patient-level split containing 1,203 training videos from 237 patients and 300 validation videos from 59 independent patients, the DINOv2-based framework achieved a mean abso-lute error (MAE) of 5.03% for Task 1, an AUC-ROC of 76.48% for Task 2, and an AUC-ROC of 70.26% for Task 3. For Task 1, the specialized ED/ES-guided model further improves performance, achieving an MAE of 4.64%. This framework demonstrates the effectiveness of foundation model repre-sentations across diverse cardio-oncology tasks and the additional benefit of physiology-guided modeling for accurate LVEF estimation.

0.18

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

cs.AI ·2026-10-02 ·Jungkyu Park, Dhruva Biswas, Joseph Cappadona, Cerise Tang, Ken G. Zeng +20 more
similarity 0.52
Abstract

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.

0.06

SYNPRED: A Synergistic Approach to Multimodal Learning for Clinical Prediction

cs.LG cs.CV ·2026-10-13 ·Ivana Janíčková, Yen Y. Tan, Thomas H. Helbich, Philipp Seeböck, Julieta Di Marco +4 more
top venuecode/data similarity 0.51
Abstract

Multimodal medical data captures complementary aspects of disease. It provides a comprehensive basis for diagnosis and the identification of biological associations linked to progression or treatment response. Established contrastive learning approaches exploit shared information across modalities, but fall short in exploiting complementary, modality-specific signals relevant for a task. Here, we propose a synergistic multimodal variational autoencoder (VAE) framework that separates task-relevant unimodal and multimodal information from instance-specific variation task-irrelevant, allowing complementary signals across modalities to be leveraged for prediction. The method yields benefits even if modalities are missing at test time. We evaluate the method on a treatment response prediction task using medical imaging and RNA data. Empirical comparison with alignment-based and multimodal VAE state-of-the-art approaches demonstrates improved multimodal prediction performance, and consistent benefits for prediction from a single modality after multimodal training. The full code can be found here: https://github.com/cirmuw/SYNPRED.

0.41